| NCT06930872 | Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates | RECRUITING | PHASE1 | 2025-06-06 | 2025-11 | 2025-10 |
| NCT07051252 | A Study of HBS-201 (Pitolisant Delayed-release) | RECRUITING | PHASE1 | 2025-05-21 | 2025-11 | 2025-11 |
| NCT06366464 | A Study of Pitolisant in Patients With Prader-Willi Syndrome | RECRUITING | PHASE3 | 2024-05-28 | 2027-07 | 2026-07 |
| NCT05458128 | A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-08-19 | 2025-09-30 | 2025-09-30 |
| NCT05156047 | A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia | COMPLETED | PHASE3 | 2022-05-25 | 2023-09-08 | 2023-09-08 |
| NCT04886518 | Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 | COMPLETED | PHASE2 | 2021-06-28 | 2024-10-31 | 2023-10-06 |
| NCT04257929 | A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension | ACTIVE_NOT_RECRUITING | PHASE2 | 2020-12-09 | 2028-09-07 | 2022-08-17 |